Exact Mass: 335.1245

Exact Mass Matches: 335.1245

Found 178 metabolites which its exact mass value is equals to given mass value 335.1245, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-acetylglucosaminylasparagine

(2S)-2-amino-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl}propanoic acid

C12H21N3O8 (335.1329)


Aspartylglycosamine, also known as n4-(beta-N-acetyl-D-glucosaminyl)-L-asparagine or 1-beta-aspartyl-N-acetyl-D-glucosaminylamine, is a member of the class of compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Aspartylglycosamine is soluble (in water) and a moderately acidic compound (based on its pKa). Aspartylglycosamine can be found primarily in urine, as well as in human spleen tissue. Within the cell, aspartylglycosamine is primarily located in the cytoplasm. Moreover, aspartylglycosamine is found to be associated with aspartylglucosaminuria, which is an inborn error of metabolism. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria corresponding to decreased activity of aspartylglycosamine amido hydrolase. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria, which is a metabolic disorder associated with decreased activity of aspartylglycosamine amido hydrolase. [HMDB]

   

gamma-Glutamyl-S-methylcysteinyl-beta-alanine

2-Amino-4-({1-[(2-carboxyethyl)-C-hydroxycarbonimidoyl]-2-(methylsulphanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


gamma-Glutamyl-S-methylcysteinyl-beta-alanine is found in pulses. gamma-Glutamyl-S-methylcysteinyl-beta-alanine is a constituent of the seeds of the mung bean (Vigna radiata). Constituent of the seeds of the mung bean (Vigna radiata). gamma-Glutamyl-S-methylcysteinyl-beta-alanine is found in pulses.

   

Tryptophyl-Methionine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-4-(methylsulphanyl)butanoic acid

C16H21N3O3S (335.1304)


Tryptophyl-Methionine is a dipeptide composed of tryptophan and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Methionyl-Tryptophan

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


Methionyl-Tryptophan is a dipeptide composed of methionine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

25C-NBOMe

2-(4-Chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine

C18H22ClNO3 (335.1288)


   

2-Amino-5-[[1-(carboxymethylamino)-3-ethylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-(ethylsulphanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


   

Cloquintocet-mexyl

1-Methylhexyl 2-[(5-chloro-8-quinolinyl)oxy]acetic acid

C18H22ClNO3 (335.1288)


   

Diethylenetriaminetetraacetic acid

2-{[2-({2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid

C12H21N3O8 (335.1329)


   

N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine monoethyl ester

2-Amino-4-({1-[(2-ethoxy-2-oxoethyl)-C-hydroxycarbonimidoyl]-2-sulphanylethyl}-C-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


   

1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan

N-[(4,5-dimethyl-1,3-thiazol-2-yl)imino]-N-(phenylamino)benzenecarboximidamide

C18H17N5S (335.1205)


   

Ramixotidine

N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulphanyl]ethyl}-1-oxo-1-pyridine-3-carboximidic acid

C16H21N3O3S (335.1304)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

3-[(2-Aminoethylamino)methyl]-3-[bis(carboxymethyl)amino]pentanedioic acid

3-{[(2-aminoethyl)amino]methyl}-3-[bis(carboxymethyl)amino]pentanedioic acid

C12H21N3O8 (335.1329)


   

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

2-(4,5-dimethyl-1,3-thiazol-2-yl)-3,5-diphenyl-2,3-dihydro-1H-1,2,3,4-tetrazole

C18H17N5S (335.1205)


   

Spiromustine

3-{2-[bis(2-chloroethyl)amino]ethyl}-1,3-diazaspiro[4.5]decane-2,4-dione

C14H23Cl2N3O2 (335.1167)


   
   
   

Cloquintocet-mexyl

Cloquintocet-mexyl

C18H22ClNO3 (335.1288)


CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10219; ORIGINAL_PRECURSOR_SCAN_NO 10218 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10248; ORIGINAL_PRECURSOR_SCAN_NO 10246 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10275; ORIGINAL_PRECURSOR_SCAN_NO 10273 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10288; ORIGINAL_PRECURSOR_SCAN_NO 10286 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10259; ORIGINAL_PRECURSOR_SCAN_NO 10258 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10304; ORIGINAL_PRECURSOR_SCAN_NO 10302

   
   

2-Amino-3-({4-[4-(tert-butyl)-1,3-thiazol-2-yl]benzylidene}amino)but-2-enedinitrile

2-Amino-3-({4-[4-(tert-butyl)-1,3-thiazol-2-yl]benzylidene}amino)but-2-enedinitrile

C18H17N5S (335.1205)


   
   

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-thienyl)-, diethyl ester

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-thienyl)-, diethyl ester

C17H21NO4S (335.1191)


   
   
   
   
   
   
   

Dictyoterphenyl A

Dictyoterphenyl A

C20H17NO4 (335.1158)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Dehydroapocavidine

Dehydroapocavidine

C20H17NO4 (335.1158)


   

Duguesuramine

Duguesuramine

C20H17NO4 (335.1158)


   
   

Desethylene-N-acetylnorfloxacin

Desethylene-N-acetylnorfloxacin

C16H18FN3O4 (335.1281)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Aspartylglycosamine

Aspartylglycosamine

C12H21N3O8 (335.1329)


   

Met-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C16H21N3O3S (335.1304)


A dipeptide formed from L-methionine and L-tryptophan residues.

   

TRP-Met

2-[2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


   

S-Methylhomoglutathione

2-amino-4-({1-[(2-carboxyethyl)carbamoyl]-2-(methylsulfanyl)ethyl}carbamoyl)butanoic acid

C12H21N3O6S (335.1151)


   

mtt formazan

mtt formazan

C18H17N5S (335.1205)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013778 - Tetrazolium Salts D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D005562 - Formazans

   

Methionyltryptophan

Methionyltryptophan

C16H21N3O3S (335.1304)


   

codeine hydrochloride

codeine hydrochloride

C18H22ClNO3 (335.1288)


   

SEMPERVIRINE, NITRATE, DIHYDRATE

SEMPERVIRINE, NITRATE, DIHYDRATE

C19H17N3O3 (335.127)


   
   

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

C17H16F3N3O (335.1245)


   

Fmoc-L-propargylglycine

Fmoc-L-propargylglycine

C20H17NO4 (335.1158)


   

Fmoc-D-Pra-OH

Fmoc-D-Pra-OH

C20H17NO4 (335.1158)


   

Boc-(S)-3-Amino-4-(3-benzothienyl)-butyric acid

Boc-(S)-3-Amino-4-(3-benzothienyl)-butyric acid

C17H21NO4S (335.1191)


   

4,5-bis(phenylmethoxy)pyridine-2-carboxylic acid

4,5-bis(phenylmethoxy)pyridine-2-carboxylic acid

C20H17NO4 (335.1158)


   

Spiromustine

Spiromustine

C14H23Cl2N3O2 (335.1167)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

2-(N-O-METHOXYPHENYL)CARBAMOYL-3-NAPHTHYL ACETATE

2-(N-O-METHOXYPHENYL)CARBAMOYL-3-NAPHTHYL ACETATE

C20H17NO4 (335.1158)


   

2C-C-NBOMe

N-(2-methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288)


   

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

C21H18FNO2 (335.1321)


   

Boc-(R)-3-Amino-4-(3-benzothienyl)-butyric acid

Boc-(R)-3-Amino-4-(3-benzothienyl)-butyric acid

C17H21NO4S (335.1191)


   

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

C18H22ClNO3 (335.1288)


   

Fmoc-3,4-dehydro-L-proline

Fmoc-3,4-dehydro-L-proline

C20H17NO4 (335.1158)


   

Benzene,2-nitro-1,4-bis(phenylmethoxy)-

Benzene,2-nitro-1,4-bis(phenylmethoxy)-

C20H17NO4 (335.1158)


   

Levofloxacin Related Compound E

Levofloxacin Related Compound E

C16H18FN3O4 (335.1281)


   

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

C24H17NO (335.131)


   

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

C18H22ClNO3 (335.1288)


   

2-(benzyloxycarbonyl)-3-(quinolin-4-yl)propanoic acid

2-(benzyloxycarbonyl)-3-(quinolin-4-yl)propanoic acid

C20H17NO4 (335.1158)


   

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

C24H17NO (335.131)


   

ML-167

(5-(4-(((5-Methylfuran-2-yl)methyl)amino)quinazolin-6-yl)furan-2-yl)methanol

C19H17N3O3 (335.127)


   

Glutathione reduced ethyl ester

Glutathione reduced ethyl ester

C12H21N3O6S (335.1151)


   

Despropylene Gatifloxacin

Despropylene Gatifloxacin

C16H18FN3O4 (335.1281)


   

3,5-bis-(Phenylmethoxy)-2-pyridinecarboxylic acid

3,5-bis-(Phenylmethoxy)-2-pyridinecarboxylic acid

C20H17NO4 (335.1158)


   
   
   

S-Ethyl glutathione

S-Ethyl glutathione

C12H21N3O6S (335.1151)


D020011 - Protective Agents > D011837 - Radiation-Protective Agents

   

L-Methionine, L-tryptophyl-

L-Methionine, L-tryptophyl-

C16H21N3O3S (335.1304)


   

N2-(4-fluorophenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

N2-(4-fluorophenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

C18H14FN5O (335.1182)


   

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

C19H17N3O3 (335.127)


   

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

C16H21N3O3S (335.1304)


   
   

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

C19H17N3O3 (335.127)


   

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

C12H21N3O8 (335.1329)


Zwitterionic form of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

a Steroid sulfate

a Steroid sulfate

C18H23O4S- (335.1317)


   

Diaminobutyryl-citryl-ethanolamine

Diaminobutyryl-citryl-ethanolamine

C12H21N3O8 (335.1329)


   

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

C12H21N3O8 (335.1329)


   

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

C18H17N5S (335.1205)


   

2-Amino-5-[[1-(carboxymethylamino)-3-ethylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-5-[[1-(carboxymethylamino)-3-ethylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C12H21N3O6S (335.1151)


   

Thr-Thr-Asp

Thr-Thr-Asp

C12H21N3O8 (335.1329)


A tripeptide composed of two L-threonine units and L-aspartic acid joined by peptide linkages.

   

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

C19H17N3O3 (335.127)


   

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

C19H17N3O3 (335.127)


   

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

C19H17N3O3 (335.127)


   

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

C19H17N3O3 (335.127)


   

8-Methoxy-1-(4-methoxyphenyl)-3-methyl-2-oxidobenzofuro[3,2-c]pyridin-2-ium

8-Methoxy-1-(4-methoxyphenyl)-3-methyl-2-oxidobenzofuro[3,2-c]pyridin-2-ium

C20H17NO4 (335.1158)


   

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-4-methoxybenzenesulfonamide

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-4-methoxybenzenesulfonamide

C17H21NO4S (335.1191)


   

ethyl 2-{[(E)-(4,4-dimethyl-2,6-dioxocyclohexyl)methylidene]amino}-5-methylthiophene-3-carboxylate

ethyl 2-{[(E)-(4,4-dimethyl-2,6-dioxocyclohexyl)methylidene]amino}-5-methylthiophene-3-carboxylate

C17H21NO4S (335.1191)


   

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

C19H17N3O3 (335.127)


   

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288)


   

Met-Ala-Asp

Met-Ala-Asp

C12H21N3O6S (335.1151)


A tripeptide composed of L-methionine, L-alanine and L-aspartic acid joined in sequence by peptide linkages.

   
   
   

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C19H17N3O3 (335.127)


   

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

C19H17N3O3 (335.127)


   

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

C19H17N3O3 (335.127)


   

4-Benzoyl-2,6-diphenylpyridine

4-Benzoyl-2,6-diphenylpyridine

C24H17NO (335.131)


   

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C19H17N3O3 (335.127)


   

N-Acetylglucosaminylasparagine

N(4)-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine

C12H21N3O8 (335.1329)


An N(4)-glycosyl-L-asparagine having (beta-N-acetyl-D-glucosaminyl as the glycosyl component.

   

tryptophylmethionine

tryptophylmethionine

C16H21N3O3S (335.1304)


   

gamma-Glutamyl-S-methylcysteinyl-beta-alanine

gamma-Glutamyl-S-methylcysteinyl-beta-alanine

C12H21N3O6S (335.1151)


   

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288)


   

Glutathione ethyl ester

Glutathione ethyl ester

C12H21N3O6S (335.1151)


Glutathione ethyl ester is a cell-permeable GSH donor and provides an efficient supply of GSH to the oocyte. Glutathione ethyl ester shows positive effect on the in vitro production of embryos by enhancement of the antioxidative defense[1].

   

LAS101057

LAS101057

C18H14FN5O (335.1182)


LAS101057 is a potent, selective, and orally efficacious A2B receptor antagonist.

   

N-Formyl-Met-Ala-Ser

N-Formyl-Met-Ala-Ser

C12H21N3O6S (335.1151)


N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.

   

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

C16H21N3O3S (335.1304)


   

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   
   

3-{4',6-dihydroxy-[1,1'-biphenyl]-3-yl}-4-methoxybenzenecarboximidic acid

3-{4',6-dihydroxy-[1,1'-biphenyl]-3-yl}-4-methoxybenzenecarboximidic acid

C20H17NO4 (335.1158)


   

2-amino-4-({1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl}-c-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl}-c-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6S (335.1151)


   

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,11,15,17,19-octaene

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),2,4(8),9,11,15,17,19-octaene

C20H17NO4 (335.1158)


   

methyl 2-{[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

methyl 2-{[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

C19H17N3O3 (335.127)


   

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

C12H21N3O8 (335.1329)


   

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

C12H21N3O8 (335.1329)


   

(2s)-2-amino-4-{[(1r)-1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-[(2-carboxyethyl)-c-hydroxycarbonimidoyl]-2-(methylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C12H21N3O6S (335.1151)


   

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

methyl 2-({9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl}amino)benzoate

methyl 2-({9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl}amino)benzoate

C19H17N3O3 (335.127)


   

3-(4-hydroxyphenyl)-5-[2-(methylamino)ethyl]-1h,7h-pyrrolo[3,2-f]indole-4,8-dione

3-(4-hydroxyphenyl)-5-[2-(methylamino)ethyl]-1h,7h-pyrrolo[3,2-f]indole-4,8-dione

C19H17N3O3 (335.127)